11 forecasters

What placebo-adjusted reduction in MADRS total score at Week 6 will be reported for MM120 (lysergide) vs. placebo in the Phase 3 Emerge trial in major depressive disorder?

community

4.91 Points

result

8.1 Points

Peer Score

community

-0.5

Average

of peers

Baseline Score

community

+6.1

0

Chance

baseline

Author:

Opened:

Jun 18, 2026

Closes:

Jun 18, 2026

Resolved:

Jul 10, 2026

Spot Scoring Time:

Jun 18, 2026

Include Bots:Yes